Librarian View

LEADER 03269cam a22005294a 4500
001 16876105
005 20231221114657.0
006 m o d
007 cr||||||||nn|n
008 221021s2023 mdu o 00 0 eng d
020
  
  
|a 9781421447049
020
  
  
|z 9781421447032
035
  
  
|a (MdBmJHUP)musev2_110680
040
  
  
|a MdBmJHUP |c MdBmJHUP
245
0
0
|a Medicine without Meds : |b Transforming Patient Care with Digital Therapies / |c edited by Dean Ho, Yoann Sapanel, Agata Blasiak.
264
  
1
|a Baltimore : |b Johns Hopkins University Press, |c 2023.
264
  
3
|a Baltimore, Md. : |b Project MUSE, |c 0000
264
  
4
|c ©2023.
300
  
  
|a 1 online resource (336 pages).
336
  
  
|a text |b txt |2 rdacontent
337
  
  
|a computer |b c |2 rdamedia
338
  
  
|a online resource |b cr |2 rdacarrier
505
0
  
|a Digital Health Solutions versus Digital Therapeutics -- Addressing Unmet Stakeholder Needs -- Addressing Unmet Clinical Needs -- Ensuring Business Viability Early -- Test, Learn, and Pivot -- Data Sourcing and Management -- Gathering Evidence: Novel Approaches to Clinical Validation -- Factors That Influence the Implementation of New Technologies -- Recommendations for DTx Implementation -- Supporting Adoption of DTx -- Channel Partnerships: The Ultimate Commercialization Strategy -- The Price Is Right : Value in the Eye of the Beholder -- Conclusion : The Future of DTx.
506
  
  
|a Access restricted by licensing agreement.
520
  
  
|a "Digital therapeutics (DTx) is a dynamic, emerging subcategory within the larger supercategory field of 'digital health' or 'digital medicine'. As defined by the nonprofit trade group, Digital Therapeutics Alliance, "DTx deliver clinical-grade therapeutic interventions to patients [that] may be used independently or in tandem with in-person or remote clinician-delivered therapy to optimize patient outcomes." In this new book, three expert editors have enlisted the support of contributors to explain what DTx represents (and how it differs from other digital health solutions), how DTX solutions can help individuals and their healthcare providers meet their health goals, and how DTx tools can be conceptualized, created, and brought to market"-- |c Provided by publisher.
588
  
  
|a Description based on print version record.
590
  
  
|a Access is available to the Yale community.
650
  
0
|a Therapeutics.
650
  
0
|a Telecommunication in medicine.
650
2
2
|a Telemedicine |x methods.
650
2
2
|a Device Approval.
650
1
2
|a Digital Technology.
650
1
2
|a Therapeutics.
700
1
  
|a Blasiak, Agata, |d 1989- |e editor.
700
1
  
|a Sapanel, Yoann, |d 1984- |e editor.
700
1
  
|a Ho, Dean, |e editor.
710
2
  
|a Project Muse. |e distributor
730
0
  
|a Project MUSE complete collection 2023.
830
  
0
|a Book collections on Project MUSE.
852
8
0
|b yulintx |h None |z Online resource
852
8
0
|z Online resource
856
4
0
|y Online book |u https://yale.idm.oclc.org/login?URL=https://muse.jhu.edu/book/110680/
902
  
  
|a Yale Internet Resource |b Yale Internet Resource >> None|DELIM|16762654
905
  
  
|a online resource
907
  
  
|a 2023-11-20T16:15:57.000Z
946
  
  
|a DO NOT EDIT. DO NOT EXPORT.
953
  
  
|a https://muse.jhu.edu/book/110680/